{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:43Z","timestamp":1759333243493,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005147","name":"Applied Basic Research Key Project of Yunnan","doi-asserted-by":"publisher","award":["2018ZF009"],"award-info":[{"award-number":["2018ZF009"]}],"id":[{"id":"10.13039\/501100005147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2017DG008","2017HC010","2017IC064"],"award-info":[{"award-number":["2017DG008","2017HC010","2017IC064"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Crouzon syndrome (CS), which results from fibroblast growth factor receptor 2 mutations, is associated with craniosynostosis, exophthalmos, and other symptoms. Herein, we report the genetic abnormalities detected in a Chinese family with autosomal dominant CS, combined with luxation of the eyeball. This luxation was a consequence of the trauma to the shallow orbits.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The proband was a 4-year-old boy. He accidentally fell, following which luxation of the bulbus oculi occurred immediately. Computed tomography and magnetic resonance imaging clearly revealed ocular proptosis. Upon physical examination, the proband, his father, and grandfather had ocular proptosis, shallow orbits, and mid-face hypoplasia. However, their hands and feet were clinically normal. Genomic DNA was extracted from the peripheral blood through a polymerase chain reaction performed for the target sequence. Genetic assessments revealed a heterozygous missense mutation (c.1012G\u2009&gt;\u2009C, p.G338R) in exon 10 of the human <jats:italic>FGFR2<\/jats:italic>, cosegregated with the disease phenotype in this family. These findings confirmed the diagnosis of CS.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>CS is usually caused by <jats:italic>FGFR2<\/jats:italic> mutations. While there are a few reports of luxation of the bulbus oculi in Chinese families with CS, the ocular proptosis, shallow orbits, combined with luxation of eyeball after trauma observed in this patient were particularly interesting. Our findings enhance the current knowledge of traumatic luxation concomitant with CS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-019-1217-8","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:29:57Z","timestamp":1571804997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inherited FGFR2 mutation in a Chinese patient with Crouzon syndrome and luxation of bulbus oculi provoked by trauma: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4766-5416","authenticated-orcid":false,"given":"Ji","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu-Lin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"unstructured":"Robin N H, Falk M J, Haldemanenglert C R. FGFR-Related Craniosynostosis Syndromes - GeneReviews\u00ae - NCBI Bookshelf [J]. Gene, 2011.","key":"1217_CR1"},{"issue":"146","key":"1217_CR2","doi-asserted-by":"publisher","first-page":"re9","DOI":"10.1126\/scisignal.3146re9","volume":"3","author":"H Miraoui","year":"2010","unstructured":"Miraoui H, Marie PJ. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal. 2010;3(146):re9.","journal-title":"Sci Signal"},{"issue":"2","key":"1217_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1086\/338758","volume":"70","author":"SH Kan","year":"2002","unstructured":"Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, Tomkins S, Verloes A, Twigg SR, Rannan-Eliya S, et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet. 2002;70(2):472\u201386.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1217_CR4","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1167\/iovs.16-21324","volume":"58","author":"FQ Rao","year":"2017","unstructured":"Rao FQ, Cai XB, Cheng FF, Cheng W, Fang XL, Li N, Huang XF, Li LH, Jin ZB. Mutations in LRP5, FZD4, TSPAN12, NDP, ZNF408, or KIF11 Genes Account for 38.7% of Chinese Patients With Familial Exudative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2017;58(5):2623\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1217_CR5","first-page":"1403","volume":"9","author":"ZL Li","year":"2016","unstructured":"Li ZL, Chen X, Zhuang WJ, Zhao W, Liu YN, Zhang FX, Ha RS, Wu JH, Zhao C, Sheng XL. FGFR2 mutation in a Chinese family with unusual Crouzon syndrome. Int J Ophthalmol. 2016;9(10):1403\u20138.","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"1217_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"11","key":"1217_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/pd.1970091109","volume":"9","author":"Y Menashe","year":"1989","unstructured":"Menashe Y, Ben Baruch G, Rabinovitch O, Shalev Y, Katzenlson MB, Shalev E. Exophthalmus--prenatal ultrasonic features for diagnosis of Crouzon syndrome. Prenat Diagn. 1989;9(11):805\u20138.","journal-title":"Prenat Diagn"},{"issue":"1","key":"1217_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1597\/14-210","volume":"53","author":"F Hariri","year":"2016","unstructured":"Hariri F, Cheung LK, Rahman ZA, Mathaneswaran V, Ganesan D. Monobloc Le fort III distraction osteogenesis for correction of severe fronto-orbital and midface hypoplasia in pediatric Crouzon syndrome. Cleft Palate Craniofac J. 2016;53(1):118\u201325.","journal-title":"Cleft Palate Craniofac J"},{"issue":"7\u20138","key":"1217_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2119\/2007-00027.Fanganiello","volume":"13","author":"RD Fanganiello","year":"2007","unstructured":"Fanganiello RD, Sertie AL, Reis EM, Yeh E, Oliveira NA, Bueno DF, Kerkis I, Alonso N, Cavalheiro S, Matsushita H, et al. Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells. Mol Med. 2007;13(7\u20138):422\u201342.","journal-title":"Mol Med"},{"issue":"3","key":"1217_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1194-275","volume":"8","author":"EW Jabs","year":"1994","unstructured":"Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao JI, Charnas LR, Jackson CE, Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet. 1994;8(3):275\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"1217_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12881-018-0607-8","volume":"19","author":"J Fan","year":"2018","unstructured":"Fan J, Li Y, Jia R, Fan X. An inherited FGFR2 mutation increased osteogenesis gene expression and result in Crouzon syndrome. BMC Med Genet. 2018;19(1):91.","journal-title":"BMC Med Genet"},{"issue":"2","key":"1217_CR12","first-page":"107","volume":"10","author":"ALT Luong","year":"2019","unstructured":"Luong ALT, Ho TT, Hoang H, Nguyen TQ, Ho TC, Tran PD, Hoang TT, Nguyen NT, Chu HH. Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome. Biomed Rep. 2019;10(2):107\u201312.","journal-title":"Biomed Rep"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1217-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-019-1217-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1217-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:09:48Z","timestamp":1603235388000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-019-1217-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1186\/s12886-019-1217-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"type":"electronic","value":"1471-2415"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"21 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This report was approved by the ethics committee at The Second People\u2019s Hospital of Yunnan province. The patient\u2019s legal guardian gave written, informed consent prior to undergoing this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The risk of identification of the patient was minimized and the case patient\u2019s legal guardian gave written, informed consent for publication of this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}